Lab-Grown blood protein tested in humans for first time
NCT ID NCT05179265
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tested a lab-made version of human serum albumin, a protein normally found in blood, in 48 healthy adults. The goal was to check safety and how the body processes the drug, not to treat any disease. It is a first step toward possibly using this protein for conditions like fluid buildup in the belly (hepatic ascites) caused by liver disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- recombinant human serum albumin
- What this could lead to
- If successful, this could lead to a safer or more reliable source of albumin for treating fluid buildup in liver disease patients.
- What could go wrong
- This is a very early Phase 1 trial in only 48 healthy people, so it cannot yet show if the drug works for any disease. Side effects are unknown at this stage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC ASCITES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100000, China
-
Shenzhen Protgen Co., Ltd.
Shenzhen, Guangdong, 100084, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.